Prostate cancer screening

What is the Prostate? The prostate is a gland in the male reproductive system, which makes and stores a fluid that nourishes sperm. The prostate gland is about the size of a walnut, and surrounds the upper part of the urethra, the tube that empties urine from the bladder. If the prostate gland grows too large, the flow of urine can be slowed or stopped. Prostate Cancer Prostate cancer is the most common type of cancer in men in the United States (other than skin cancer), and accounts for more

Testicular Cancer Testicular cancer is a cancer that only occurs on men. This cancer forms in the testicles, or testes, of a male. The testicles are positioned inside of the scrotum which is next to the penis and looks like a bag of skin. The purpose of the testicles is to produce sperm and they contain sex hormones. “Reproductive bodies called germ cells develop into sperm through a process of cellular division called meiosis (4).” Normally cell division is regulated but in testicular cancer

Arsenic is an invisible killer that many people may be drinking as I write this article. It was such a problem for the United States, that in 2001, the US Environmental Protection Agency had to lower the maximum level of arsenic allowed in drinking water from 50 micrograms per liter (ug/L) to 10 micrograms per liter (ug/Liter) (Ryker, 2001). Despite this change in policy, this issue of arsenic contamination continues, and is even more widespread in many more places outside of the United States. Unlike

Bladder cancer is a cancer that forms in a person’s bladder and often begins with cells that line the bladder. The early symptoms of bladder cancer are blood in the urine, frequent or painful urination, back or pelvic pain. My father had bladder cancer in his early 90’s and I did not give much thought to what caused the cancer since most of his siblings had previously passed due to some form of cancer. However, I have now learned that bladder cancer is mainly common in someone that is older than

INTRODUCTION Prostate cancer is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males. Incidence rates vary more than 25-fold worldwide, with the highest rates in the developed countries this may be due to the widespread use of prostate-specific antigen testing and subsequent prostate biopsy in these regions [1]. Overall, the complex morphology, histologic heterogeneity, and the early signs of high malignant potential preclude a straightforward assessment

units and improved at discharge to 105 (IQR 96, 112) units, the cognitive FIM sub-score showed no improvement pre- and post-discharge whilst the motor FIM sub-score had a modest improvement of 12 (IQR 3, 14) units (Table 2). Elderly patients with cancer demonstrated a median increase in total FIM score, pre- to post-discharge from the GEM unit (p=0.005), of 12, which was driven by

researching health communication and medical decision-making using transcripts of real patient encounters from men with early stage prostate cancer and from women deciding between surgical treatment

urologists showed that over 60% choose RP and PLND as first-step treatment in HR PCa 27. In our consolidate clinical experience, RP can be seen as the best single treatment modality of high-risk prostate cancer in the properly selected men, therefore classification of a patient as having high-risk cancer should not preclude surgical treatment. Survival outcomes, to the

Low Dose Rate (LDR) Prostate Brachytherapy Introduction According to the American Cancer Society, nearly 161,360 new cases of prostate cancer are expected to be diagnosed with an estimated 26,730 prostate-cancer specific deaths in 2017. Prostate cancer is the third leading cause of cancer death in American men, behind lung and colorectal cancer. Current available treatments for prostate cancer include active surveillance, surgery, radiation therapy (external beam or/and brachytherapy), cryosurgery

Prostatectomy covers several surgical procedures to remove all or some of the prostate gland. The prostate gland is located in the lower abdomen of men, beneath the urinary bladder. It surrounds the urethra, which transfers urine from the bladder to the penis. There are different prostatectomy procedures depending on the treatment required. These include robotic-assisted radical prostatectomy, open radical prostatectomy, laparoscopic radical prostatectomy, and Open simple prostatectomy. Robotic-assisted